已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Onychomycosis

医学 皮肤病科
作者
Shari R. Lipner,Richard K. Scher
出处
期刊:Journal of The American Academy of Dermatology [Elsevier BV]
卷期号:80 (4): 853-867 被引量:235
标识
DOI:10.1016/j.jaad.2018.05.1260
摘要

Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice. It is an important problem because it may cause local pain, paresthesias, difficulties performing activities of daily living, and impair social interactions. The epidemiology, risk factors, and clinical presentation and diagnosis of onychomycosis were discussed in the first article in this continuing medical education series. In this article, we review the prognosis and response to onychomycosis treatment, medications for onychomycosis that have been approved by the US Food and Drug Administration, and off-label therapies and devices. Methods to prevent onychomycosis recurrences and emerging therapies are also described. Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice. It is an important problem because it may cause local pain, paresthesias, difficulties performing activities of daily living, and impair social interactions. The epidemiology, risk factors, and clinical presentation and diagnosis of onychomycosis were discussed in the first article in this continuing medical education series. In this article, we review the prognosis and response to onychomycosis treatment, medications for onychomycosis that have been approved by the US Food and Drug Administration, and off-label therapies and devices. Methods to prevent onychomycosis recurrences and emerging therapies are also described. Journal Based CME Instructions and InformationJournal of the American Academy of DermatologyVol. 80Issue 4Preview Full-Text PDF CorrectionJournal of the American Academy of DermatologyVol. 81Issue 2PreviewLipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-67. Exam: 868. Full-Text PDF CME examinationJournal of the American Academy of DermatologyVol. 80Issue 4Preview Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ding应助欢喜的尔烟采纳,获得10
刚刚
2秒前
熊猫完成签到 ,获得积分10
2秒前
哩哩完成签到 ,获得积分10
3秒前
科研通AI2S应助有意义采纳,获得10
4秒前
4秒前
4秒前
5秒前
YUYU芋头完成签到,获得积分10
5秒前
义气莫茗完成签到 ,获得积分10
6秒前
Zhaoyuemeng完成签到 ,获得积分10
8秒前
拼搏的寒凝完成签到 ,获得积分10
9秒前
有意义完成签到,获得积分10
10秒前
鹅鹅发布了新的文献求助10
10秒前
fhw完成签到 ,获得积分10
11秒前
WEileen完成签到 ,获得积分0
11秒前
hhh完成签到 ,获得积分10
11秒前
木卫二完成签到 ,获得积分10
11秒前
小蓝完成签到 ,获得积分10
12秒前
科研通AI6.1应助annathd采纳,获得10
14秒前
sanqian完成签到 ,获得积分10
14秒前
qianyixingchen完成签到 ,获得积分10
15秒前
知秋完成签到 ,获得积分10
15秒前
czz完成签到,获得积分10
16秒前
17秒前
芭蕾恰恰舞完成签到,获得积分10
19秒前
Zero完成签到 ,获得积分10
19秒前
喬老師完成签到,获得积分10
19秒前
19秒前
优雅枫叶完成签到 ,获得积分10
19秒前
科研通AI6.1应助Libaoen采纳,获得200
20秒前
怕孤单的羊完成签到 ,获得积分10
21秒前
Xxxxzzz完成签到,获得积分10
21秒前
li完成签到 ,获得积分10
22秒前
学不完了完成签到 ,获得积分10
22秒前
22秒前
科研天才完成签到 ,获得积分10
22秒前
24秒前
叠森完成签到,获得积分10
24秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Malcolm Fraser : a biography 700
Handbook of Optical Systems,Volume 6:Advanced Physical Optics 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6515194
求助须知:如何正确求助?哪些是违规求助? 8308476
关于积分的说明 17756259
捐赠科研通 5616983
什么是DOI,文献DOI怎么找? 2924855
邀请新用户注册赠送积分活动 1901915
关于科研通互助平台的介绍 1763243

今日热心研友

注:热心度 = 本日应助数 + 本日被采纳获取积分÷10